Science that works.
Mallia develops evidence-based solutions for targeted hair regeneration – with a focus on immunological research, therapeutic relevance and visible results.
When research creates visible change.
Mallia stands for evidence-based development that makes an impact. Our approach is to harness the latest findings specifically for applications where conventional solutions are not sufficient.
The focus is on the targeted support of the body's own regeneration processes – particularly in connection with hair loss and immunological triggers. The aim is to make precisely developed active ingredients clinically relevant – comprehensible, trustworthy and effective.
Two specialized divisions operate within the Mallia world:
Mallia Therapeutics develops immunomodulating agents for medical applications – with a particular focus on inflammation-induced hair loss, wound healing and related indications.
Mallia Aesthetics concentrates on cosmetic products for daily use – scientifically based, clearly formulated and targeted at hair follicles, eyelashes, beards and brows.
Our milestones.
Research & discovery:
Company foundation:
Focus on Therapeutics:
Expansion to include Aesthetics:
Product launch 8T3:
Pipeline development:
Our leadership team.
Mallia's management team combines decades of experience in immunological research, drug development and entrepreneurial implementation – with the clear goal of translating scientific progress into effective solutions for hair growth.
The focus is on the development of innovative, evidence-based approaches to support the body's own regeneration processes. From basic research to product innovation, the team is united by a common understanding: impact does not come from promises, but from validated results.
Prof. Dr Alexander Steinkasserer
One of the leading international scientists in the field of the CD83 protein
Over 35 years of experience in immunology with over 170 peer reviewed publications
Professor & Head of the Department of Immunomodulation at the University Hospital Erlangen
Industry experience at Novartis and Baxter, among others
Our office management.
As Office Manager, Marion Mielenhausen supports the Mallia leadership team with great dedication in coordinating appointments, organizing business travel and events, and overseeing all aspects of office management and preparatory accounting.
Our highly experienced and distinguished SAB members.
Our Scientific Advisory Board (SAB) is composed of globally recognized experts. Learn more about our highly qualified and distinguished SAB members.
Prof. Dr med. Ulrike Blume-Peytavi
Worldwide leading experts in the field of hair growth, hair disorders and skin care, with more than 370 publications and 35 years of experience in the field
Director of the Clinical Research Center for Hair and Skin Science, at the Charité-Universitätsmedizin Berlin
Leading expert in dermatology and allergology
Performed many clinical trails in the context of hair growth, including Androgenetic alopecia (AGA) and Alopecia areata (AA)
Founding member of the European Hair Research Society (EHRS), honorary member of the American Dermatological Association, member of the EADV and the ESPD
Dr Claire A. Higgins
Leading research expert in the field of hair follicle development, with over 30 years industry experience, more than 15 years practical knowledge in the field resulting in > 50 publications
Department of Bioengineering, Imperial College London, London, United Kingdom
President of the European Hair Research Society
Committee member of the Royal Society Research Grants Committee
Alopecia UK Research Committee member
Vice President of the Institute of Trichologists
British Skin Foundation Large Grants Committee member
Dr Gillian Westgate
Very well known in the field of skin and hair research with more than 30 years industry experience
PhD in hair biology research at the University of Edinburgh
Commercial manager at the University of Bradford, responsible for the develop of partnerships between industry and academic research
Her industry experience was obtained at Unilever Research (UK), where she led ther scalp and hair biology research program for many years
Past president of the European Hair Research Society and a member of the Society of Cosmetic Scientists
Co-founder and Chair of Cosmetics Cluster UK (CCUK), a networking organization for the sector
Dr Geert Cauwenbergh
Worldwide leader and known Biotechnology & Healthcare Entrepreneur in the field of hair growth
Author of > 100 publications, co-editor and co-author of 5 books
Vice President Technology Transfer and External Developments – Johnson & Johnson Consumer and Personal Care Products, Skillman NJ, USA
Vice President R & D, Johnson & Johnson Skin Research Center, Skillman, USA
Vice President Product Development, Johnson & Johnson Consumer, Skillman, USA, and member of the Management Board of the US J&J ConsumerCompany
President and CEO of RXi/PhioPharmaceuticals(NASDAQ:PHIO)
Member Board of Directors of AblynxNV (Belgium): 2007-2013 – Public Company sold to Sanofi for 3.9 billion euro (US$4.35 billion)
President & Chief Executive Officer Phio Pharmaceuticals Corp.
Prof. Dr med. Franklin Kiesewetter
A leading clinician in the field of dermatology, histology and hair research with more then 70 publications and over 40 years of professional experience in the field
Former head of Andrology and Histology, Department of Dermatology, University Hospital Erlangen
Sozialstiftung Bamberg, Dermatology practice
Leading expert regarding pathology, histology and cellular composition of hair follicles
Performed basic as well as applied research in the field of hair growth
Treated countless patients suffering from alopecia and was involved in many clinical trials
Always up to date.
Research doesn't stop with us – it starts anew every day. In the news section you will find the latest information on innovations, product developments and insights behind the scenes at Mallia.
